Research on Autism Spectrum Disorders (R03 Clinical Trial Optional)
(PA-21-199)
National Institute of Mental Health Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
Application Receipt Date(s):
Multiple dates, see announcement.
Research on Autism Spectrum Disorders (R21 Clinical Trial Optional)
(PA-21-200)
National Institute of Mental Health Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s):
Multiple dates, see announcement.
Research on Autism Spectrum Disorders (R01 Clinical Trial Optional)
(PA-21-201)
National Institute of Mental Health Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s):
Multiple dates, see announcement.
Short-Term Mentored Research Career Enhancement Award to Promote Diversity (K18 No Independent Clinical Trials)
(PA-21-214)
National Human Genome Research Institute
Application Receipt Date(s):
June 12, 2021, February 12, 2022, February 12, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
(PAR-21-162)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s):
August 10, 2021, February 9, 2022, August 9, 2022, February 9, 2023, August 9, 2023, February 9, 2024
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial Not Allowed)
(RFA-HG-21-006)
National Human Genome Research Institute
Application Receipt Date(s):
June 25, 2021; March 1, 2022; February 1, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial Not Allowed)
(RFA-HG-21-007)
National Human Genome Research Institute
Application Receipt Date(s):
June 25, 2021; March 1, 2022; February 1, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)
(RFA-HG-21-008)
National Human Genome Research Institute
Application Receipt Date(s):
June 25, 2021; March 1, 2022; February 1, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.